Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) on Tuesday, plunged -4.25% from the previous trading day, before settling in for the closing price of $105.18. Within the past 52 weeks, RYTM’s price has moved between $45.90 and $116.00.
A company in the Healthcare sector has dropped its sales by -2.34% annually for the last half of the decade. The company achieved an average annual earnings per share of 27.69%. With a float of $62.33 million, this company’s outstanding shares have now reached $66.68 million.
Rhythm Pharmaceuticals Inc (RYTM) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Rhythm Pharmaceuticals Inc is 6.60%, while institutional ownership is 106.30%. The most recent insider transaction that took place on Nov 20 ’25, was worth 351,750. In this transaction Chief Human Resources Officer of this company sold 3,350 shares at a rate of $105.00, taking the stock ownership to the 20,814 shares. Before that another transaction happened on Nov 20 ’25, when Company’s Officer proposed sale 3,350 for $103.15, making the entire transaction worth $345,552.
Rhythm Pharmaceuticals Inc (RYTM) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.72 earnings per share (EPS) for the period topping the consensus outlook (set at -0.73) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.79 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.69% per share during the next fiscal year.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Trading Performance Indicators
Rhythm Pharmaceuticals Inc (RYTM) is currently performing well based on its current performance indicators. A quick ratio of 4.53 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 38.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.10, a number that is poised to hit -0.79 in the next quarter and is forecasted to reach -2.64 in one year’s time.
Technical Analysis of Rhythm Pharmaceuticals Inc (RYTM)
Let’s dig in a bit further. During the last 5-days, its volume was 0.71 million. That was better than the volume of 0.66 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 29.99%.
During the past 100 days, Rhythm Pharmaceuticals Inc’s (RYTM) raw stochastic average was set at 52.25%, which indicates a significant increase from 19.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 4.67 in the past 14 days, which was higher than the 3.75 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $104.39, while its 200-day Moving Average is $80.85. However, in the short run, Rhythm Pharmaceuticals Inc’s stock first resistance to watch stands at $104.16. Second resistance stands at $107.62. The third major resistance level sits at $109.51. If the price goes on to break the first support level at $98.81, it is likely to go to the next support level at $96.92. The third support level lies at $93.46 if the price breaches the second support level.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Key Stats
Market capitalization of the company is 6.72 billion based on 66,736K outstanding shares. Right now, sales total 130,130 K and income totals -260,600 K. The company made 51,300 K in profit during its latest quarter, and -52,900 K in sales during its previous quarter.
